Inspira Technologies' Jan 2025 Form 6-K: Major Product Reveal & Compliance Insights

Here are the key points extracted from the financial report specified:

1. Document Type: This is a Form 6-K report, which is typically used by foreign private issuers to provide information to the SEC.
2. Company Name: Inspira Technologies Oxy B.H.N. Ltd.
3. Report Date: The report is for the month of January 2025, specifically noted as Report No. 3.
4. Commission File Number: 001-40303.
5. Address: The principal executive office is located at 2 Ha-Tidhar St., Ra’anana 4366504, Israel.
6. Annual Report Filing Indication: The registrant indicates it files annual reports under Form 20-F.
7. Press Release: On January 14, 2025, Inspira Technologies issued a press release titled “Inspira™ Technologies Unveils Modular Configuration for Revolutionary VORTX™ Blood Oxygenation Delivery Technology.” This indicates a potential advancement in their product offerings.
8. Incorporation by Reference: The first four paragraphs and the section titled “Forward-Looking Statements” from the press release are incorporated by reference into the company's Registration Statements on Forms F-3 and S-8. This implies that the information is significant for ongoing investor relations and compliance purposes.
9. Exhibit: The press release is listed as Exhibit 99.1, which is a common practice for significant announcements.
10. Signatory Information: The report was signed by Dagi Ben-Noon, the Chief Executive Officer, on January 14, 2025.

These points highlight the regulatory compliance aspects of the company, a significant product announcement, and the management's involvement in reporting, which are crucial for stakeholders and investors reviewing the company's performance and strategy.